Physician profile
John Scovell
NPI 1790816122
$9,194.85
in general payments reported to CMS, 2019-2025
18 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,770 · 2020: $317 · 2021: $3,910 · 2022: $81.73 · 2023: $224 · 2024: $497 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,834.42 | 2019-2024 | |
| Arthrex, INC. | $2,986.16 | 2019 | |
| Stryker Corporation | $726.20 | 2019-2025 | Gravity Synchfix, Iconix, Variax |
| Smith+Nephew, INC. | $355.12 | 2023-2025 | Spatial Frame, Rf20000, Ultrabutton |
| Vericel Corporation | $256.49 | 2019-2025 | Maci |
| Pacira Therapeutics, INC. | $192.82 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $179.58 | 2019-2025 | Euflexxa |
| Linvatec Corporation | $115.65 | 2023-2024 | Biobrace 23mm |
| Shoulder Innovations, INC. | $110.18 | 2024 | Inset System |
| Horizon Therapeutics Plc | $97.15 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $69.09 | 2020-2022 | |
| Depuy Synthes Sales INC. | $66.07 | 2019-2024 | Monovisc, Orthovisc |
| Orthofix Medical, INC. | $60.31 | 2019-2025 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $53.58 | 2019 | |
| Baudax Bio INC. | $38.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $22.62 | 2019 | |
| Heron Therapeutics, INC. | $17.05 | 2025 | Zynrelef |
| Fidia Pharma USA INC. | $13.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scovell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.